Advertisement
Actualités Forex
Canadian Market Roughly Flat In Cautious Trade After Paring Early Losses
The Canadian market is down marginally Wednesday afternoon with stocks turning in a mixed performance amid lingering concerns about interest rates and slowing growth.
RTTNews |
il y a 783
Swiss Market Fails To Hold Early Gains, Ends Modestly Lower
After a weak start and a subsequent recovery that resulted in a positive spell till about an hour past noon on Wednesday, the Switzerland market fell into negative territory and eventually ended the day's session modestly lower.
RTTNews
|
il y a 783
European Stocks Close Lower After Hawkish Comments From Powell
European stocks closed weak on Wednesday, extending recent losses, as Federal Reserve Chair Jerome Powell reaffirmed the central bank's commitment to bringing inflation down to its target rate of 2%.
RTTNews
|
il y a 783
Canadian Dollar Advances After Upbeat Retail Sales Data
The Canadian dollar climbed against its major counterparts during the New York session on Wednesday, as the nation's retail sales exceeded expectations in April.
RTTNews
|
il y a 783
Aldeyra Therapeutics Gets CRL From FDA For NDA Of ADX-2191 To Treat Primary Vitreoretinal Lymphoma
Biotechnology company Aldeyra Therapeutics, Inc. (ALDX) announced Wednesday the receipt of a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for the 505(b)(2) New Drug Application (NDA) of ADX-2191 (methotrexate for injection, USP), an investigational drug candidate, for the treatment of primary vitreoretinal lymphoma (PVRL).
RTTNews
|
il y a 783
Powell Expects Further Rate Hikes As Inflation Remains Stubbornly Elevated
Following last week's widely expected pause, the Federal Reserve is likely to resume raising interest rates later this year, Fed Chair Jerome Powell said during testimony before the House Financial Services Committee on Wednesday.
RTTNews
|
il y a 783
DiaMedica Therapeutics Says FDA Lifts Clinical Hold On DM199 Phase 2/3 Trial For Ischemic Stroke
Biopharmaceutical company DiaMedica Therapeutics Inc. (DMAC) announced Wednesday that the U.S. Food and Drug Administration (FDA) has removed the clinical hold placed on the investigational new drug application for its ReMEDy2 phase 2/3 clinical trial studying DM199 in the treatment of acute ischemic stroke (AIS).
RTTNews
|
il y a 783
more news
Bay Street Likely To See Subdued Start
Canadian shares are likely to open on a somewhat subdued note on Wednesday, amid a lack of positive triggers.
RTTNews
|
il y a 783
Winnebago Industries Q3 Net Profit Halves, But Adj. EPS Tops Estimates
Recreation vehicles maker Winnebago Industries, Inc. (WGO) reported on Wednesday that third-quarter net income plunged to $59.1 million or $1.71 per share from $117.2 million or $3.57 per share in the prior-year quarter.
RTTNews
|
il y a 783
Pound Drops On Rate Hike Worries After Strong Inflation Data
The pound fell against its major rivals in the European session on Wednesday, as the nation's inflation came in well above consensus expectations in May, raising concerns about a bigger rate hike from the Bank of England at the monetary policy decision on Thursday.
RTTNews
|
il y a 783
Bluebird Bio Says FDA Accepts BLA For Lovotibeglogene Autotemcel For Priority Review
bluebird bio, Inc. (BLUE) announced Wednesday that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for lovotibeglogene autotemcel (lovo-cel) for priority review. The agency has set a Prescription Drug User Fee Act (PDUFA) goal date of December 20, 2023.
RTTNews
|
il y a 783
Sensex, Nifty End At Record Highs Despite Weak Global Cues
Indian shares eked out modest gains on Wednesday despite weak cues from global markets.
RTTNews
|
il y a 783
Twitter Sued By Employees Over Promised But Unpaid Bonuses
Twitter Inc. employees have sued the social media major for allegedly refusing to pay 2022 bonuses, even after promising to pay 50 percent of targeted bonus. In a lawsuit filed in San Francisco federal court, the current and former Twitter employees claim that in the months leading up to Elon Musk's acquisition of Twitter in October 2022, the company's executives, including former Chief Financial.
RTTNews
|
il y a 783
Stay up to date!
Add Actualités to your browser
Add To Chrome
